Novel gene switches

Handbook of Experimental Pharmacology

Volumn 178, Issue , 2007, Pages 73-105

  Weber, W ^a   Fussenegger, M ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Bioengineering; Biopharmaceuticals; Gene Switch; Gene therapy; Inducible expression

Indexed keywords

ANIMAL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; GENOME; REGULATOR GENE; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENES, SWITCH; GENOME; TRANSCRIPTION, GENETIC;

EID: 33846910280     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-35109-2_4     Document Type: Article

References (139)

1. Abruzzese RV, Godin D, Mehta V, Perrard JL, French M, Nelson W, Howell G, Coleman M, O'Malley BW, Nordstrom JL (2000) Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system. Mol Ther 2:276-287
2. Akagi K, Kanai M, Saya H, Kozu T, Berns A (2001) A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain. Nucleic Acids Res 29:e23
3. Apparailly F, Millet V, Noel D, Jacquet C, Sany J, Jorgensen C (2002) Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 13:1179-1188
4. Atkinson MR, Savageau MA, Myers JT, Ninfa AJ (2003) Development of genetic circuitry exhibiting toggle switch or oscillatory behavior in Escherichia coli. Cell 113:597-607
5. Aubel D, Morris R, LennonB, RimannM, KaufmannH, FolcherM,Bailey JE, ThompsonCJ, Fussenegger M (2001) Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics. J Antibiot (Tokyo) 54:44-55
6. Aubrecht J, Manivasakam P, Schiestl RH (1996) Controlled gene expression in mammalian cells via a regulatory cascade involving the tetracycline transactivator and lac repressor. Gene 172:227-231
7. Auricchio A, Rivera V, Clackson T, O'Connor E,Maguire A, Tolentino M, Bennett J,Wilson J (2002) Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol Ther 6:238-242
8. Baim SB, Labow MA, Levine AJ, Shenk T (1991) A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-Dthiogalactopyranoside. Proc Natl Acad Sci U S A 88:5072-5076
9. Baron U, Freundlieb S, Gossen M, Bujard H (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23:3605-3606
10. Baron U, Gossen M, Bujard H (1997) Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 25:2723-2729
11. Bassler BL (2002) Small talk. Cell-to-cell communication in bacteria. Cell 109:421-424
12. Bellefroid EJ, Poncelet DA, Lecocq PJ, Revelant O,Martial JA (1991) The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc Natl Acad Sci U S A 88:3608-3612
13. Belteki G, Gertsenstein M, Ow DW, Nagy A (2003) Site-specific cassette exchange and germline transmission withmouse ES cells expressing phiC31 integrase. Nat Biotechnol 21:321-324
14. Berger C, Blau CA, Huang ML, Iuliucci JD, Dalgarno DC, Gaschet J, Heimfeld S, Clackson T, Riddell SR (2004) Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model. Blood 103:1261-1269
15. Bi JX, Shuttleworth J, Al-Rubeai M (2004) Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1-arrested CHO cells. Biotechnol Bioeng 85:741-749
16. Boijoux O, Boutonnet C, Giamarchi C, Favre G, Vagner S, Faye JC (2005) Chemical-based translational induction of luciferase expression: an efficient tool for in vivo screening of protein farnesylation inhibitors. Mol Pharmacol 67:1829-1833
17. Boorsma M, Nieba L, Koller D, Bachmann MF, Bailey JE, RennerWA (2000) A temperatureregulated replicon-based DNA expression system. Nat Biotechnol 18:429-432
18. Boorsma M, Hoenke S, Marrero A, Fischer R, Bailey JE, RennerWA, Bachmann MF (2002) Bioprocess applications of a Sindbis virus-based temperature-inducible expression system. Biotechnol Bioeng 79:602-609
19. Boutonnet C, Boijoux O, Bernat S, Kharrat A, Favre G, Faye JC, Vagner S (2004) Pharmacological-based translational inductionof transgene expressioninmammaliancells.EMBO Rep 5:721-727
20. Branda CS, Dymecki SM (2004) Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6:7-28
21. Brekasis D, Paget MS (2003) A novel sensor of NADH/NAD+ redox poise in Streptomyces coelicolor A3 (2) . Embo J 22:4856-4865
22. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D (1997) Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci U S A 94:14559-14563
23. Brocard J, Feil R, Chambon P, Metzger D (1998) A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor. Nucleic Acids Res 26: 4086-4090
24. Buchholz F, Angrand PO, Stewart AF (1998) Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol 16:657-662
25. Crittenden M, GoughM, Chester J, Kottke T, Thompson J, Ruchatz A, Clackson T, Cosset FL, Chong H, Diaz RM, Harrington K, Alvarez Vallina L, Vile R (2003) Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy. Cancer Res 63:3173-3180
26. Darteil R, Wang M, Latta-Mahieu M, Caron A, Mahfoudi A, Staels B, Thuillier V (2002) Efficient gene regulation by PPAR gamma and thiazolidinediones in skeletalmuscle and heart. Mol Ther 6:265-271
27. Eaton RW (1997) p-Cymene catabolic pathway in Pseudomonas putida F1: cloning and characterization of DNA encoding conversion of p-cymene to p-cumate. J Bacteriol 179:3171-3180
28. Elowitz MB, Leibler S (2000) A synthetic oscillatory network of transcriptional regulators. Nature 403:335-338
29. FelenbokB, FlipphiM,Nikolaev I (2001) Ethanol catabolism inAspergillus nidulans: amodel system for studying gene regulation. Prog Nucleic Acid Res Mol Biol 69:149-204
30. Fussenegger M (2001) The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 17:1-51
31. FusseneggerM,Mazur X, Bailey JE (1998a) pTRIDENT,Anovel vector family for tricistronic gene expression in mammalian cells. Biotechnol Bioeng 57:1-10
32. FusseneggerM, Schlatter S, Datwyler D,Mazur X, Bailey JE (1998b) Controlled proliferation bymultigenemetabolic engineering enhances the productivity of Chinesehamster ovary cells. Nat Biotechnol 16:468-472
33. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE (2000) Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18:1203-1208
34. Fux C, Langer D, Fussenegger M (2004a) Dual-regulated myoD-and msx1-based interventions in C2C12-derived cells enable precisemyogenic/osteogenic/ adipogenic lineage control. J Gene Med 6:1159-1169
35. Fux C, Mitta B, Kramer BP, Fussenegger M (2004b) Dual-regulated expression of C/EBPalpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. Nucleic Acids Res 32:e1
36. Fux C, Moser S, Schlatter S, Rimann M, Bailey JE, Fussenegger M (2001) Streptograminand tetracycline-responsive dual regulated expression of p27 (Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells. Nucleic Acids Res 29:e19
37. Fux C, Weber W, Daoud-El Baba M, Heinzen C, Aubel D, Fussenegger M (2003) Novel macrolide-adjustable bidirectional expression modules for coordinated expression of two different transgenes in mice. J Gene Med 5:1067-1079
38. Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, Galun E, Gazit Z, Jorgensen C, Gazit D (2004) Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9:587-595
39. Gardner TS, Cantor CR, Collins JJ (2000) Construction of a genetic toggle switch in Escherichia coli. Nature 403:339-342
40. Ginsburg DS, Calos MP (2005) Site-specific integration with phiC31 integrase for prolonged expression of therapeutic genes. Adv Genet 54:179-187
41. Gonzalez-NicoliniV, FusseneggerM (2005) Anovel binary adenovirus-based dual-regulated expression system for independent transcription control of two different transgenes. J Gene Med 7:1573-1585
42. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547-5551
43. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769
44. HanazonoY,NagashimaT, TakatokuM, ShibataH,AgeyamaN,AsanoT,UedaY,DunbarCE, Kume A, Terao K, Hasegawa M, Ozawa K (2002) In vivo selective expansion of genemodified hematopoietic cells in a nonhuman primate model. Gene Ther 9:1055-1064
45. Hartenbach S, Fussenegger M (2005) Autoregulated, bidirectional and multicistronic gasinducible mammalian as well as lentiviral expression vectors. J Biotechnol 120:83-98
46. Hunter NL, Awatramani RB, Farley FW, Dymecki SM (2005) Ligand-activated Flpe for temporally regulated gene modifications. Genesis 41:99-109
47. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D (1999) Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER (T) and Cre-ER (T2) recombinases. Nucleic Acids Res 27:4324-4327
48. Iuliucci JD, Oliver SD, Morley S,Ward C,Ward J, Dalgarno D, Clackson T, Berger HJ (2001) Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers. J Clin Pharmacol 41:870-879
49. Jamieson AC, Miller JC, Pabo CO (2003) Drug discovery with engineered zinc-finger proteins. Nat Rev Drug Discov 2:361-368
50. Jin L, Siritanaratkul N, EmeryDW, Richard RE,Kaushansky K, Papayannopoulou T, Blau CA (1998) Targeted expansion of genetically modified bone marrow cells. Proc Natl Acad Sci U S A 95:8093-8097
51. Kelm JM, Kramer BP, Gonzalez-Nicolini V, Ley B, FusseneggerM (2004) Synergies of microtissue design, viral transduction and adjustable transgene expression for regenerative medicine. Biotechnol Appl Biochem 39:3-16
52. Kobinger GP, Deng S, Louboutin JP, Vatamaniuk M, Rivera VM, Lian MM, Markmann JF, Clackson T, Raper SE, Matschinsky F, Wilson JM (2005) Pharmacologically regulated regeneration of functional human pancreatic islets. Mol Ther 11:105-111
53. Kramer BP, FusseneggerM (2005) Hysteresis in a synthetic mammalian gene network. Proc Natl Acad Sci U S A 102:9517-9522
54. Kramer BP,WeberW, FusseneggerM (2003) Artificial regulatory networks and cascades for discretemultilevel transgene control in mammalian cells. Biotechnol Bioeng 83:810-820
55. Kramer BP, Fischer C, Fussenegger M (2004a) BioLogic gates enable logical transcription control in mammalian cells. Biotechnol Bioeng 87:478-484
56. Kramer BP, Viretta AU, Daoud-El-Baba M, Aubel D, Weber W, Fussenegger M (2004b) An engineered epigenetic transgene switch in mammalian cells. Nat Biotechnol 22:867-870
57. Kramer BP, Fischer M, Fussenegger M (2005) Semi-synthetic mammalian gene regulatory networks. Metab Eng 7:241-250
58. Kume A, Ito K, Ueda Y, Hasegawa M, UrabeM,Mano H, Ozawa K (1999) A G-CSF receptorgyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells. Biochem Biophys Res Commun 260:9-12
59. Kuninger D, Stauffer D, Eftekhari S,Wilson E, Thayer M, Rotwein P (2004) Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system. Hum Gene Ther 15:1287-1292
60. Latta-Mahieu M, Rolland M, Caillet C, Wang M, Kennel P, Mahfouz I, Loquet I, Dedieu JF, Mahfoudi A, Trannoy E, Thuillier V (2002) Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression.HumGene Ther 13:1611-1620
61. Lauth M, Spreafico F, Dethleffsen K, Meyer M (2002) Stable and efficient cassette exchange under non-selectable conditions by combined use of two site-specific recombinases. Nucleic Acids Res 30:e115
62. Lebherz C, Auricchio A,Maguire AM, Rivera VM, TangW, Grant RL, Clackson T, Bennett J, Wilson JM (2005) Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Hum Gene Ther 16:178-186
63. Luker KE, Smith MC, Luker GD, Gammon ST, Piwnica-Worms H, Piwnica-Worms D (2004) Kinetics of regulated protein-protein interactions revealedwith firefly luciferase complementation imaging in cells and living animals. ProcNatl Acad SciUS A 101:12288-12293
64. Luo B, Heard AD, Lodish HF (2004) Small interfering RNA production by enzymatic engineering of DNA (SPEED) . Proc Natl Acad Sci U S A 101:5494-5499
65. Malleret G,HaditschU, GenouxD, JonesMW, BlissTV,VanhooseAM,Weitlauf C,KandelER, WinderDG,Mansuy IM (2001) Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104:675-686
66. Malphettes L,FusseneggerM (2004) Macrolide-andtetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives. Biotechnol Bioeng 88:417-425
67. Malphettes L,Weber CC, El-BabaMD, Schoenmakers RG,AubelD,WeberW, FusseneggerM (2005) A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1. Nucleic Acids Res 33:e107
68. Meents H, Enenkel B,Werner RG, FusseneggerM (2002) p27Kip1-mediated controlled proliferation technology increases constitutive sICAM production in CHO-DUKX adapted for growth in suspension and serum-free media. Biotechnol Bioeng 79:619-627
69. Mitta B, Weber CC, Rimann M, Fussenegger M (2004) Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression. Nucleic Acids Res 32:e106
70. Mitta B,Weber CC, Fussenegger M (2005) In vivo transduction of HIV-1-derived lentiviral particles engineered formacrolide-adjustable transgene expression. J GeneMed 7:1400-1408
71. Miyake K, Flygare J, Kiefer T, Utsugisawa T, Richter J, Ma Z, Wiznerowicz M, Trono D, Karlsson S (2005) Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond-blackfan anemia using inducible expression of siRNA against RPS19. Mol Ther 11:627-637
72. Moser S, Schlatter S, Fux C, Rimann M, Bailey JE, FusseneggerM (2000) An update of pTRIDENT multicistronic expression vectors: pTRIDENTs containing novel streptograminresponsive promoters. Biotechnol Prog 16:724-735
73. Moser S, Rimann M, Fux C, Schlatter S, Bailey JE, Fussenegger M (2001) Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cells. J Gene Med 3:529-549
74. Neddermann P, Gargioli C, Muraglia E, Sambucini S, Bonelli F, De Francesco R, Cortese R (2003) A novel, inducible, eukaryotic gene expression system based on the quorumsensing transcription factor TraR. EMBO Rep 4:159-165
75. Neff T, Horn PA, Valli VE, Gown AM,Wardwell S,Wood BL, von Kalle C, SchmidtM, Peterson LJ, Morris JC, Richard RE, Clackson T, Kiem HP, Blau CA (2002) Pharmacologically regulated in vivo selection in a large animal. Blood 100:2026-2031
76. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376
77. Nor JE, Hu Y, Song W, Spencer DM, Nunez G (2002) Ablation of microvessels in vivo upon dimerization of iCaspase-9. Gene Ther 9:444-451
78. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA (2003) PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther 14:923-928
79. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE (2005) Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11:797-803
80. Palli SR, Kapitskaya MZ, Kumar MB, Cress DE (2003) Improved ecdysone receptor-based inducible gene regulation system. Eur J Biochem 270:1308-1315
81. Payen E, Bettan M, Henri A, Tomkiewitcz E, Houque A, Kuzniak I, Zuber J, Scherman D, Beuzard Y (2001) Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy. J Gene Med 3:498-504
82. Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J (2005) Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med 7:803-817
83. Pollett JB, Zhu YX, Gandhi S, Bali M, Masih-Khan E, Li Z, Wen XY, Stewart AK (2003) RU486-inducible retrovirus-mediated caspase-3 overexpression is cytotoxic to bcl-xLexpressing myeloma cells in vitro and in vivo. Mol Ther 8:230-237
84. Pollock R, Clackson T (2002) Dimerizer-regulated gene expression. Curr Opin Biotechnol 13:459-467
85. Pollock R, Giel M, Linher K, Clackson T (2002) Regulation of endogenous gene expression with a small-molecule dimerizer. Nat Biotechnol 20:729-733
86. PollockR, IssnerR,Zoller K,Natesan S, RiveraVM,ClacksonT (2000) Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci U S A 97:13221-13226
87. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr, Holt DA, Gilman M (1996) A humanized system for pharmacologic control of gene expression. Nat Med 2:1028-1032
88. Rivera VM, Wang X, Wardwell S, Courage NL, Volchuk A, Keenan T, Holt DA, Gilman M, Orci L, Cerasoli F Jr, Rothman JE, Clackson T (2000) Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287:826-830
89. Rivera VM, Gao GP, Grant RL, SchnellMA, Zoltick PW, Rozamus LW, Clackson T,Wilson JM (2005) Long-termpharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105:1424-1430
90. Rollins CT, Rivera VM,WoolfsonDN,Keenan T,Hatada M,Adams SE, Andrade LJ, YaegerD, van SchravendijkMR,HoltDA, Gilman M, Clackson T (2000) A ligand-reversible dimerization system for controlling protein-protein interactions. Proc Natl Acad Sci U S A 97:7096-7101
91. Rossi F, Charlton CA, Blau HM (1997) Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. ProcNatl Acad SciUS A 94:8405-8410
92. Samakoglu S, Bohl D, Heard JM (2002) Mechanisms leading to sustained reversion of betathalassemia in mice by doxycycline-controlled Epo delivery from muscles. Mol Ther 6:793-803
93. Schlatter S, Fussenegger M (2003) Novel CNBP-and La-based translation control systems for mammalian cells. Biotechnol Bioeng 81:1-12
94. Schlatter S, Senn C, Fussenegger M (2003) Modulation of translation-initiation in CHO-K1 cells by rapamycin-induced heterodimerization of engineered eIF4G fusion proteins. Biotechnol Bioeng 83:210-225
95. Schmitz ML, Baeuerle PA (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. Embo J 10:3805-3817
96. Sebti SM (2005) Protein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy. Cancer Cell 7:297-300
97. Senzer N, Mani S, Rosemurgy A, Nemunaitis J, Cunningham C, Guha C, Bayol N, Gillen M, Chu K, Rasmussen C, Rasmussen H,KufeD,WeichselbaumR,HannaN (2004) TNFerade biologic, an adenovectorwith a radiation-induciblepromoter, carrying thehumantumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 22:592-601
98. Shariat SF, Desai S, SongW, Khan T, Zhao J, Nguyen C, Foster BA,Greenberg N, Spencer DM, Slawin KM (2001) Adenovirus-mediated transfer of inducible caspases: a novel death switch gene therapeutic approach to prostate cancer. Cancer Res 61:2562-2571
99. Shiner EK, Reddy S, Timmons C, Li G, Williams SC, Rumbaugh KP (2004) Construction of a bacterial autoinducer detection system in mammalian cells. Biol Proced Online 6:268-276
100. Sickmier EA, Brekasis D, Paranawithana S, Bonanno JB, Paget MS, Burley SK, Kielkopf CL (2005) X-ray structure of a Rex-family repressor/NADHcomplex insights into the mechanism of redox sensing. Structure (Camb) 13: 43-54
101. Singer O, Yanai A, Verma IM (2004) Silence of the genes. Proc Natl Acad Sci U S A 101:5313-5314
102. Srour MA, Fechner H, Wang X, Siemetzki U, Albert T, Oldenburg J, Hanfland P, Poller W, Brackmann HH, Schwaab R (2003) Regulation of human factor IX expression using doxycycline-inducible gene expression system. Thromb Haemost 90:398-405
103. Sudomoina M, Latypova E, Favorova OO, Golemis EA, Serebriiskii IG (2004) A gene expression systemofferingmultiple levels of regulation: the Dual Drug Control (DDC) system. BMC Biotechnol 4:9
104. Takahashi K, Saishin Y, Saishin Y, Silva RL, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ, Liau G, Kaleko M, Connelly S, Luo T, Campochiaro PA (2003) Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. Faseb J 17:896-898
105. Takano E, Chakraburtty R, Nihira T, Yamada Y, Bibb MJ (2001) A complex role for the gamma-butyrolactone SCB1 in regulating antibiotic production in Streptomyces coelicolor A3 (2) . Mol Microbiol 41:1015-1028
106. Tang YL, Tang Y, Zhang YC, Agarwal A, Kasahara H, Qian K, Shen L, Phillips MI (2005) A hypoxia-inducible vigilant vector systemfor activating therapeutic genes in ischemia. Gene Ther 12:1163-1170
107. Tascou S, Sorensen TK, Glenat V, Wang M, Lakich MM, Darteil R, Vigne E, Thuillier V (2004) Stringent rosiglitazone-dependent gene switch in muscle cells without effect on myogenic differentiation. Mol Ther 9:637-649
108. Triezenberg SJ, Kingsbury RC, McKnight SL (1988) Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev 2:718-729
109. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 97:7963-7968
110. Vilaboa N, Fenna M, Munson J, Roberts SM, Voellmy R (2005) Novel gene switches for targeted and timed expression of proteins of interest. Mol Ther 12:290-298
111. Viretta AU, Fussenegger M (2004) Modeling the quorum sensing regulatory network of human-pathogenic Pseudomonas aeruginosa. Biotechnol Prog 20:670-678
112. Wadhwa R, Kaul SC, Miyagishi M, Taira K (2004) Vectors for RNA interference. Curr Opin Mol Ther 6:367-372
113. Wang J, Voutetakis A, Zheng C, Baum BJ (2004) Rapamycin control of exocrine protein levels in saliva after adenoviral vector-mediated gene transfer. Gene Ther 11:729-733
114. Weber W, Fussenegger M (2002) Artificial mammalian gene regulation networks-novel approaches for gene therapy and bioengineering. J Biotechnol 98:161-187
115. WeberW, Fussenegger M (2004a) Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering. Curr Opin Biotechnol 15:383-391
116. WeberW, Fussenegger M (2004b) Inducible gene expression in mammalian cells and mice. Methods Mol Biol 267:451-466
117. Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, FusseneggerM (2002a) Macrolide-based transgene control inmammalian cells and mice. Nat Biotechnol 20:901-907
118. Weber W, Marty RR, Keller B, Rimann M, Kramer BP, Fussenegger M (2002b) Versatile macrolide-responsive mammalian expression vectors for multiregulated multigene metabolic engineering. Biotechnol Bioeng 80:691-705
119. WeberW,MartyRR, LinkN, EhrbarM, Keller B,WeberCC,ZischAH,HeinzenC, DjonovV, Fussenegger M (2003a) Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) system. Nucleic Acids Res 31:e69
120. Weber W, Schoenmakers R, Spielmann M, El-Baba MD, Folcher M, Keller B, Weber CC, Link N, van de Wetering P, Heinzen C, Jolivet B, Sequin U, Aubel D, Thompson CJ, Fussenegger M (2003b) Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression inmammalian cells and mice. Nucleic Acids Res 31:e71
121. Weber W, Rimann M, Spielmann M, Keller B, Daoud-El Baba M, Aubel D, Weber CC, Fussenegger M (2004) Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22:1440-1444
122. Weber CC, Link N, Fux C, Zisch AH, Weber W, Fussenegger M (2005a) Broad-spectrum protein biosensors for class-specific detection of antibiotics. Biotechnol Bioeng 89:9-17
123. WeberW, Malphettes L, de Jesus M, Schoenmakers R, El-Baba MD, Spielmann M, Keller B, Weber CC, van de Wetering P, Aubel D, Wurm FM, Fussenegger M (2005b) Engineered Streptomyces quorum-sensing components enable inducible siRNA-mediated translation control in mammalian cells and adjustable transcription control in mice. J Gene Med 7:518-525
124. WeberW, Malphettes L, RinderknechtM, Schoenmakers RG, SpielmannM, Keller B, van de Wetering P,Weber CC, FusseneggerM (2005c) Quorum-sensing-based toolbox for regulatable transgene and siRNAexpression in mammalian cells. Biotechnol Prog 21:178-185
125. Weber W, Rimann M, de Glutz FN, Weber E, Memmert K, Fussenegger M (2005d) Gasinducible product gene expression in bioreactors. Metab Eng 7:174-181
126. Weber W, Spielmann M, Daoud El-Baba M, Keller B, Aubel D, Fussenegger M (2005e) Tobacco smoke as inducer for gas phase-controlled transgene expression in mammalian cells and mice. Biotechnol Bioeng 90:893-897
127. WeberW, Link N, FusseneggerM (2006) A genetic redox sensor for mammalian cells.Metab Eng 8:270-280
128. Werner NS,WeberW, FusseneggerM, Geisse S (2005) A novel AIR-induced gene expression system in HEK.EBNA cells and its applications. In: Smith R (ed) Cell Technology for Cell Products. Springer, Dordrecht, The Netherlands, in press
129. Werstuck G, Green MR (1998) Controlling gene expression in living cells through small molecule-RNA interactions. Science 282:296-298
130. Wilsey J, Zolotukhin S, Prima V, Shek EW, Matheny MK, Scarpace PJ (2002) Hypothalamic delivery of doxycycline-inducible leptin gene allows for reversible transgene expression and physiological responses. Gene Ther 9:1492-1499
131. Worthington J, McCarthy HO, Barrett E, Adams C, Robson T, Hirst DG (2004) Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J Gene Med 6:673-680
132. Xia H,Mao Q, Paulson HL, Davidson BL (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20:1006-1010
133. Yao F, Svensjo T,Winkler T, Lu M, Eriksson C, Eriksson E (1998) Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther 9:1939-1950
134. Yen L, Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, Mulligan RC (2004) Exogenous control of mammalian gene expression through modulation of RNA selfcleavage. Nature 431:471-476
135. Zabala M, Wang L, Hernandez-Alcoceba R, Hillen W, Qian C, Prieto J, Kramer MG (2004) Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res 64:2799-2804
136. Zerby D, Sakhuja K, Reddy PS, Zimmerman H, Kayda D, Ganesh S, Pattison S, Brann T, Kadan MJ, Kaleko M, Connelly S (2003) In vivo ligand-inducible regulation of gene expression in a gutless adenoviral vector system. Hum Gene Ther 14:749-761
137. Zhao HF, Boyd J, Jolicoeur N, Shen SH (2003) A coumermycin/novobiocin- regulated gene expression system. Hum Gene Ther 14:1619-1629
138. Zhao S,Weinreich MA, Ihara K, Richard RE, Blau CA (2004) In vivo selection of genetically modified erythroid cells using a jak2-based cell growth switch. Mol Ther 10:456-468
139. Zhao S, Zoller K, Masuko M, Rojnuckarin P, Yang XO, Parganas E, Kaushansky K, Ihle JN, Papayannopoulou T, Willerford DM, Clackson T, Blau CA (2002) JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells. Embo J 21:2159-2167